Physician

Christopher C Lai, MD

According to 2025 Medicare claims, Christopher Lai, MD (NPI: 1508905159) practices orthopedic surgery in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is CHRISTOPHER C LAI MD A PROFESSIONAL CORPORATION (NPI: 1235312216; TIN: 330880816) and primary practice location at 92243-2800.

Lai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 891 traditional Medicare patients, billed 13,238 HCPCS/CPT codes, and received $531,822 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 672 prescription claims across 269 beneficiaries totaling $7,869 in drug costs, led by Cefpodoxime Proxetil (Cefpodoxime Proxetil). DME data shows 18 claims. Open Payments data shows 13 records totaling $2,319. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $6,779 and ending at $7,869. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,375 and ending at $668.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	921	6,101	$456,056
2016	937	6,545	$509,458
2017	972	5,650	$485,052
2018	848	5,032	$448,263
2019	700	11,985	$367,688
2020	623	35,593	$322,062
2021	685	75,954	$504,032
2022	699	39,744	$467,275
2023	802	6,013	$489,343
2024	891	13,238	$531,822

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	223	413	$6,779
2016	201	363	$6,945
2017	190	339	$8,386
2018	174	323	$10,966
2019	145	294	$4,407
2020	145	267	$2,876
2021	165	267	$3,570
2022	205	436	$6,366
2023	237	590	$11,787
2024	269	672	$7,869

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	25	$1,779
2016	96	108	$6,680
2017	75	113	$7,835
2018	60	105	$3,745
2019	12	27	$640
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	18	18	$951
2023	21	22	$1,234
2024	18	18	$1,018

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	336	336	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	554	1,617	$96
20611	Aspiration and/or injection of fluid large joint using ultrasound guidance	391	1,202	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	454	737	$68
73562	X-ray of knee, 3 views	231	260	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cefpodoxime Proxetil	Cefpodoxime Proxetil	99	497	$3,219
Gabapentin	Gabapentin	194	5,870	$1,621
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	187	1,236	$1,603
Ibuprofen	Ibuprofen	54	1,543	$289
Acetaminophen-Codeine	Acetaminophen With Codeine	39	192	$268

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	N	18	18	$1,018

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$2,319	Smith+Nephew, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher C. Lai, MD?

Tedicare shows public-source Medicare data for Christopher C. Lai, MD (NPI 1508905159), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher C. Lai, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher C. Lai, MD?

Christopher C. Lai, MD is linked to CHRISTOPHER C LAI MD A PROFESSIONAL CORPORATION (billing NPI 1235312216) in the available physician profile data.

Does Christopher C. Lai, MD have Open Payments data?

Christopher C. Lai, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.